Elderly Lung Cancer Patients May Live Longer With Chemotherapy And Radiation Together
Elderly patients with inoperable non-small-cell lung cancer (NSCLC) who take a daily dose of carboplatin (a chemotherapy drug), in addition to radiotherapy, live significantly longer than those who receive radiotherapy alone, say Japanese researchers. The study is published Online First in The Lancet Oncology. Shinji Atagi from Kinki-chuo Chest Medical Center, Osaka, Japan, said: [Until now] evidence supporting standard treatment with concurrent chemoradiotherapy was from clinical trials in which elderly, especially frail elderly patients, were under-represented... (Source: Health News from Medical News Today)
FDA Grants Priority Review For Arixtra® (fondaparinux Sodium) In The Treatment Of Acute Coronary Syndromes
GlaxoSmithKline plc [LSE and NYSE: GSK] announced today that the supplemental new drug application for its anticoagulant product Arixtra® (fondaparinux sodium) Injection has been accepted for priority review by the United States Food and Drug Administration. This application was based on positive results from two pivotal, Phase III trials (OASIS 5 and 6) that evaluated Arixtra in the treatment of a broad spectrum of patients with acute coronary syndromes (ACS). [click link for full article] (Source: Cardiovascular / Cardiology News From Medical News Today)
